SEARCH

SEARCH BY CITATION

References

  • Acikgoz O., Gonenc S., Kayatekin B. M., Uysal N., Pekcetin C. and Semin I. (1998) Methamphetamine causes lipid peroxidation and an increase in superoxide dismutase activity in the rat striatum. Brain Res. 813, 200202.
  • Acikgoz O., Gonenc S., Kayatekin B. M., Pekcetin C., Uysal N., Dayi A., Semin I. and Gure A. (2000) The effects of single dose of methamphetamine on lipid peroxidation levels in the rat striatum and prefrontal cortex. Eur. Neuropsychopharmacol. 10, 415418.
  • Adams J. D. Jr, Klaidman L. K., Odunze I. N., Shen H. C. and Miller C. A. (1991) Alzheimer's and Parkinson's disease. Brain levels of glutathione, glutathione disulfide, and vitamin E. Mol. Chem. Neuropathol. 14, 213226.
  • Ames B. N., Cathcart R., Schwiers E. and Hochstein P. (1981) Uric acid provides an antioxidant defense in humans against oxidant- and radical-caused aging and cancer: a hypothesis. Proc. Natl Acad. Sci. USA 78, 68586862.
  • Aspberg A. and Tottmar O. (1994) Oxidative stress decreases antioxidant enzyme activities in reaggregation cultures of rat brain cells. Free Radic. Biol. Med. 17, 511516.
  • Benzi G. and Moretti A. (1995) Age- and peroxidative stress-related modifications of the cerebral enzymatic activities linked to mitochondria and the glutathione system. Free Radic. Biol. Med. 19, 77101.
  • Binienda Z., Simmons C., Hussain S., Slikker W. Jr and Ali S. F. (1998) Effect of acute exposure to 3-nitropropionic acid on activities of endogenous antioxidants in the rat brain. Neurosci. Lett. 251, 173176.
  • Cadet J. L. and Brannock C. (1998) Free radicals and the pathobiology of brain dopamine systems. Neurochem. Int. 32, 117131.
  • Cadet J. L., Sheng P., Ali S., Rothman R., Carlson E. and Epstein C. (1994) Attenuation of methamphetamine-induced neurotoxicity in copper/zinc superoxide dismutase transgenic mice. J. Neurochem. 62, 380383.
  • Ceballos-Picot I. (1997) The Role of Oxidative Stress in Neuronal Death. Landes Bioscience, Austin.
  • Cubells J. F., Rayport S., Rajendran G. and Sulzer D. (1994) Methamphetamine neurotoxicity involves vacuolation of endocytic organelles and dopamine-dependent intracellular oxidative stress. J. Neurosci. 14, 22602271.
  • D'Almeida V., Camarini R., Azzalis L. A., Mattei R., Junqueira V. B. and Carlini E. A. (1995) Antioxidant defense in rat brain after chronic treatment with anorectic drugs. Toxicol. Lett. 81, 101110.
  • De Vito M. J. and Wagner G. C. (1989) Methamphetamine-induced neuronal damage: a possible role for free radicals. Neuropharmacology 28, 11451150.
  • Desole M. S., Esposito G., Migheli R., Fresu L., Sircana S., Zangani D., Miele M. and Miele E. (1995a) Cellular defence mechanisms in the striatum of young and aged rats subchronically exposed to manganese. Neuropharmacology 34, 289295.
  • Desole M. S., Miele M., Esposito G., Fresu L. G., Migheli R., Zangani D., Sircana S., Grella G. and Miele E. (1995b) Neuronal antioxidant system and MPTP-induced oxidative stress in the striatum and brain stem of the rat. Pharmacol. Biochem. Behav. 51, 581592.
  • Fernandez-Checa J. C. and Kaplowitz N. (1990) The use of monochlorobimane to determine hepatic GSH levels and synthesis. Anal. Biochem. 190, 212219.
  • Fibiger H. C. and McGeer E. G. (1971) Effect of acute and chronic methamphetamine treatment on tyrosine hydroxylase activity in brain and adrenal medulla. Eur. J. Pharmacol. 16, 176180.
  • Fiske C. H. and SubbaRow Y. (1925) The colorimetric determination of phosphorus. J. Biol. Chem. 66, 375.
  • Fitzmaurice P. S., Ang L., Guttman M., Rajput A. H., Furukawa Y. and Kish S. J. (2003) Nigral glutathione deficiency is not specific for idiopathic Parkinson's disease. Mov. Disord. 18, 969976.
  • Frey K., Kilbourn M. and Robinson T. (1997) Reduced striatal vesicular monoamine transporters after neurotoxic but not after behaviorally-sensitizing doses of methamphetamine. Eur. J. Pharmacol. 334, 273279.
  • Gipp J. J., Chang C. and Mulcahy R. T. (1992) Cloning and nucleotide sequence of a full-length cDNA for human liver gamma-glutamylcysteine synthetase. Biochem. Biophys. Res. Commun. 185, 2935.
  • Gotz M. E., Janetzky B., Pohli S. et al. (2001) Chronic alcohol consumption and cerebral indices of oxidative stress: is there a link? Alcohol. Clin. Exp. Res. 25, 717725.
  • Griffith O. W. and Mulcahy R. T. (1999) The enzymes of glutathione synthesis: gamma-glutamylcysteine synthetase. Adv. Enzymol. Relat. Areas Mol. Biol. 73, 209267.
  • Halliwell B. and Cross C. E. (1994) Oxygen-derived species: their relation to human disease and environmental stress. Environ. Health. Perspect. 102, 512.
  • Harold C., Wallace T., Friedman R., Gudelsky G. and Yamamoto B. (2000) Methamphetamine selectively alters brain glutathione. Eur. J. Pharmacol. 400, 99102.
  • Harvey P. R., Ilson R. G. and Strasberg S. M. (1989) The simultaneous determination of oxidized and reduced glutathiones in liver tissue by ion pairing reverse phase high performance liquid chromatography with a coulometric electrochemical detector. Clin. Chim. Acta 180, 203212.
  • Harvey D. C., Lacan G. and Melega W. P. (2000a) Regional heterogeneity of dopaminergic deficits in vervet monkey striatum and substantia nigra after methamphetamine exposure. Exp. Brain. Res. 133, 349358.
  • Harvey D. C., Lacan G., Tanious S. P. and Melega W. P. (2000b) Recovery from methamphetamine reduced long-term nigrostriatal dopaminergic deficits without substantia nigra cell loss. Brain. Res. 871, 259270.
  • Hirata H., Ladenheim B., Rothman R. B., Epstein C. and Cadet J. L. (1995) Methamphetamine-induced serotonin neurotoxicity is mediated by superoxide radicals. Brain Res. 677, 345347.
  • Huang C. S., Anderson M. E. and Meister A. (1993) Amino acid sequence and function of the light subunit of rat kidney gamma-glutamylcysteine synthetase. J. Biol. Chem. 268, 2057820583.
  • Hung H. C. and Lee E. H. (1998) MPTP produces differential oxidative stress and antioxidative responses in the nigrostriatal and mesolimbic dopaminergic pathways. Free Radic. Biol. Med. 24, 7684.
  • Iriyama K., Iwamoto T., Yoshiura M. and Aoki T. (1986) Postmortem changes in uric acid and ascorbic acid in human cerebral cortex tissues excised after cardiac death. Biochem. Med. Metab. Biol. 36, 186193.
  • Jayanthi S., Ladenheim B. and Cadet J. L. (1998) Methamphetamine-induced changes in antioxidant enzymes and lipid peroxidation in copper/zinc-superoxide dismutase transgenic mice. Ann. N. Y. Acad. Sci. 844, 92102.
  • Kim H. C., Jhoo W. K., Choi D. Y., Im D. H., Shin E. J., Suh J. H., Floyd R. A. and Bing G. (1999) Protection of methamphetamine nigrostriatal toxicity by dietary selenium. Brain Res. 851, 7686.
  • Kish S. J., Olivier A., Dubeau F., Robitaille Y. and Sherwin A. L. (1988) Increased activity of cholineacetyltransferase and acetylcholinesterase in actively epileptic human cerebral cortex. Epilepsy Res. 2, 227231.
  • Laruelle M., Abi-Dargham A., Van Dyck C. H., Rosenblatt W., Zea-Ponce Y., Zoghbi S. S., Baldwin R. M., Charney D. S., Hoffer P. B. and Kung H. F. (1995) SPECT imaging of striatal dopamine release after amphetamine challenge. J. Nucl. Med. 36, 11821190.
  • Lee C.-Y. (1982) Glucose-6-phosphate dehydrogenase from mouse. Meth. Enzymol. 89, 252257.
  • Linder J. C., Young S. J. and Groves P. M. (1995) Electron microscopic evidence for neurotoxicity in the basal ganglia. Neurochem. Int. 26, 195202.
  • Martinez D., Slifstein M., Broft A. et al. (2003) Imaging human mesolimbic dopamine transmission with positron emission tomography. Part II: amphetamine-induced dopamine release in the functional subdivisions of the striatum. J. Cereb. Blood Flow Metab. 23, 285300.
  • McCann U. D., Wong D. F., Yokoi F., Villemagne V., Dannals R. F. and Ricaurte G. A. (1998) Reduced striatal dopamine transporter density in abstinent methamphetamine and methcathinone users: evidence from positron emission tomography studies with [11C]WIN-35,428. J. Neurosci. 18, 84178422.
  • Moszczynska A., Turenne S. and Kish S. J. (1998) Rat striatal levels of the antioxidant glutathione are decreased following binge administration of methamphetamine. Neurosci. Lett. 255, 4952.
  • Moszczynska A., Fitzmaurice P., Ang L., Kalasinsky K. S., Schmunk G. A., Peretti F. J., Aiken S. S., Wickham D. J. and Kish S. J. (2004) Why is Parkinsonism not a feature of human methamphetamine users? Brain 127, 363370.
  • Mueller K. (1990) The effects of haloperidol and amphetamine on ascorbic acid and uric acid in caudate and nucleus accumbens of rats as measured by voltammetry in vivo. Life Sci. 47, 735742.
  • Ohtsuki T., Matsumoto M., Suzuki K., Taniguchi N. and Kamada T. (1993) Effect of transient forebrain ischemia on superoxide dismutases in gerbil hippocampus. Brain Res. 620, 305309.
  • Paglia D. E. and Valentine W. N. (1967) Studies on the quantitative and qualitative characterization of erythrocyte glutathione peroxidase. J. Lab. Clin. Med. 70, 158169.
  • Parks D. A. and Granger D. N. (1986) Xanthine oxidase: biochemistry, distribution and physiology. Acta Physiol. Scand. Suppl. 548, 8799.
  • Perry T. L. (1982) Cerebral amino acid pools, in Handbook of Neurochemistry (LajthaA., ed.), pp. 151180. Plenum Publishing Corporation, New York, NY USA.
  • Perry T. L., Hansen S. and Gandham S. S. (1981) Postmortem changes of amino compounds in human and rat brain. J. Neurochem. 36, 406410.
  • Perry T. L., Godin D. V. and Hansen S. (1982) Parkinson's disease: a disorder due to nigral glutathione deficiency? Neurosci. Lett. 33, 305310.
  • Rabinovic A. D., Lewis D. A. and Hastings T. G. (2000) Role of oxidative changes in the degeneration of dopamine terminals after injection of neurotoxic levels of dopamine. Neuroscience 101, 6776.
  • Rahman I., Bel A., Mulier B., Donaldson K. and MacNee W. (1998) Differential regulation of glutathione by oxidants and dexamethasone in alveolar epithelial cells. Am. J. Physiol. 275, L80L86.
  • Reid L. L., Botta D., Lu Y., Gallagher E. P. and Kavanagh T. J. (1997a) Molecular cloning and sequencing of the cDNA encoding the catalytic subunit of mouse glutamate-cysteine ligase. Biochim. Biophys. Acta 1352, 233237.
  • Reid L. L., Botta D., Shao J., Hudson F. N. and Kavanagh T. J. (1997b) Molecular cloning and sequencing of the cDNA encoding mouse glutamate-cysteine ligase regulatory subunit. Biochim. Biophys. Acta 1353, 107110.
  • Riederer P., Sofic E., Rausch W. D., Schmidt B., Reynolds G. P., Jellinger K. and Youdim M. B. (1989) Transition metals, ferritin, glutathione, and ascorbic acid in parkinsonian brains. J. Neurochem. 52, 515520.
  • Riley H. A. (1960) An Atlas of the Basal Ganglia, Brainstem and Spinal Cord. Hafner, New York.
  • Saponjic R. M., Mueller K., Krug D. and Kunko P. M. (1994) The effects of haloperidol, scopolamine, and MK-801 on amphetamine-induced increases in ascorbic and uric acid as determined by voltammetry in vivo. Pharmacol. Biochem. Behav. 48, 161168.
  • Seelig G. F. and Meister A. (1985) Glutathione biosynthesis; gamma-glutamylcysteine synthetase from rat kidney. Meth. Enzymol. 113, 379390.
  • Seiden L. S., Fischman M. W. and Schuster C. R. (19751976) Long-term methamphetamine induced changes in brain catecholamines in tolerant rhesus monkeys. Drug Alcohol Depend. 1, 215219.
  • Sekine Y., Iyo M., Ouchi Y., Matsunaga T., Tsukada H., Okada H., Yoshikawa E., Futatsubashi M., Takei N. and Mori N. (2001) Methamphetamine-related psychiatric symptoms and reduced brain dopamine transporters studied with PET. Am. J. Psychiatry 158, 12061214.
  • Sen C. K. (1997) Nutritional biochemistry of cellular glutathione. Nutr. Biochem. 8, 660672.
  • Seyfried J., Soldner F., Kunz W. S., Schulz J. B., Klockgether T., Kovar K. A. and Wullner U. (2000) Effect of 1-methyl-4-phenylpyridinium on glutathione in rat pheochromocytoma PC 12 cells. Neurochem. Int. 36, 489497.
  • Shimizu T., Iwanaga M., Yasunaga A., Urata Y., Goto S., Shibata S. and Kondo T. (1998) Protective role of glutathione synthesis on radiation-induced DNA damage in rabbit brain. Cell. Mol. Neurobiol. 18, 299310.
  • Sian J., Dexter D. T., Lees A. J., Daniel S., Agid Y., Javoy-Agid F., Jenner P. and Marsden C. D. (1994a) Alterations in glutathione levels in Parkinson's disease and other neurodegenerative disorders affecting basal ganglia. Ann. Neurol. 36, 348355.
  • Sian J., Dexter D. T., Lees A. J., Daniel S., Jenner P. and Marsden C. D. (1994b) Glutathione-related enzymes in brain in Parkinson's disease. Ann. Neurol. 36, 356361.
  • Singhal S. S., Godley B. F., Chandra A., Pandya U., Jin G. F., Saini M. K., Awasthi S. and Awasthi Y. C. (1999) Induction of glutathione S-transferase hGST 5.8 is an early response to oxidative stress in RPE cells. Invest. Ophthalmol. Vis. Sci. 40, 26522659.
  • Smith I. K., Vierheller T. L. and Thorne C. A. (1988) Assay of glutathione reductase in crude tissue homogenates using 5,5′-dithiobis (2-nitrobenzoic acid). Anal. Biochem. 175, 408413.
  • Sonsalla P. K., Jochnowitz N. D., Zeevalk G. D., Oostveen J. A. and Hall E. D. (1996) Treatment of mice with methamphetamine produces cell loss in the substantia nigra. Brain Res. 738, 172175.
  • Spearman M. E. and Leibman K. C. (1984) Effects of aging on hepatic and pulmonary glutathione S-transferase activities in male and female Fischer 344 rats. Biochem. Pharmacol. 33, 13091313.
  • Tate S. S. and Meister A. (1985) gamma-Glutamyl transpeptidase from kidney. Meth. Enzymol. 113, 400419.
  • Thiffault C., Aumont N., Quirion R. and Poirier J. (1995) Effect of MPTP and 1-deprenyl on antioxidant enzymes and lipid peroxidation levels in mouse brain. J. Neurochem. 65, 27252733.
  • Thompson S. A., White C. C., Krejsa C. M., Diaz D., Woods J. S., Eaton D. L. and Kavanagh T. J. (1999) Induction of glutamate-cysteine ligase (gamma-glutamylcysteine synthetase) in the brains of adult female mice subchronically exposed to methylmercury. Toxicol. Lett. 110, 19.
  • Volkow N. D., Chang L., Wang G. J. et al. (2001a) Loss of dopamine transporters in methamphetamine abusers recovers with protracted abstinence. J. Neurosci. 21, 94149418.
  • Volkow N. D., Chang L., Wang G. J. et al. (2001b) Association of dopamine transporter reduction with psychomotor impairment in methamphetamine abusers. Am. J. Psychiatry 158, 377382.
  • Wilson J. M., Kalasinsky K. S., Levey A. I., Bergeron C., Reiber G., Anthony R. M., Schmunk G. A., Shannak K., Haycock J. W. and Kish S. J. (1996) Striatal dopamine nerve terminal markers in human, chronic methamphetamine users. Nat. Med. 2, 699703.
  • Wise R. A. (1996) Neurobiology of addiction. Curr. Opin. Neurobiol. 6, 243251.
  • Woolverton W. L., Ricaurte G. A., Forno L. S. and Seiden L. S. (1989) Long-term effects of chronic methamphetamine administration in rhesus monkeys. Brain Res. 486, 7378.
  • Yamamoto B. K. and Zhu W. (1998) The effects of methamphetamine on the production of free radicals and oxidative stress. J. Pharmacol. Exp. Ther. 287, 107114.
  • Yan N. and Meister A. (1990) Amino acid sequence of rat kidney gamma-glutamylcysteine synthetase. J. Biol. Chem. 265, 15881593.
  • Yokoyama H., Tsuchihashi N., Kasai N., Matsue T., Uchida I., Mori N., Ohya-Nishiguchi H. and Kamada H. (1997) Hydrogen peroxide augmentation in a rat striatum after methamphetamine injection as monitored in vivo by a Part-disk microelectrode. Biosens. Bioelectron. 12, 10371041.
  • Yoo H. Y., Chang M. S. and Rho H. M. (1999) The activation of the rat copper/zinc superoxide dismutase gene by hydrogen peroxide through the hydrogen peroxide-responsive element and by paraquat and heat shock through the same heat shock element. J. Biol. Chem. 274, 2388723892.